Not yet time for a paradigm shift away from angiotensin inhibitors in chronic kidney disease, but due diligence required

被引：1
|
作者：
Swift, P. A. [1 ]
Andrews, P. A. [1 ]
机构：
[1] Epsom & St Helier Univ Hosp NHS Trust, SW Thames Renal & Transplantat Unit, London, England
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2010年 / 64卷 / 10期
关键词：
CONVERTING-ENZYME-INHIBITOR; BLOOD-PRESSURE CONTROL; RENAL OUTCOMES; PROGRESSION; BENAZEPRIL; BLOCKADE; DIET; RISK;
D O I：
10.1111/j.1742-1241.2010.02472.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1332 / 1333
页数：2
相关论文
共 50 条
  • [1] Hypoxia in chronic kidney disease: towards a paradigm shift?
    Faivre, Anna
    Scholz, Carsten C.
    de Seigneux, Sophie
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (10) : 1782 - 1790
  • [2] Hypoxia-inducible factor prolyl hydroxylase inhibitors: a paradigm shift for treatment of anemia in chronic kidney disease?
    Souza, Ernane
    Cho, Katherine H.
    Harris, Shelby T.
    Flindt, Naomi R.
    Watt, Richard K.
    Pai, Amy Barton
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (08) : 831 - 844
  • [3] Accepting aortic aneurysms as a chronic disease: The required paradigm shift in the endograft era
    Suckow, Bjoern Dominik
    [J]. JOURNAL OF VASCULAR SURGERY, 2023, 77 (05) : 1375 - 1376
  • [4] Introduction: Sex and Gender in Kidney Health and Disease: Time for a Paradigm Shift
    Ahmed, Sofia B.
    [J]. SEMINARS IN NEPHROLOGY, 2022, 42 (02) : 99 - 100
  • [5] Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease
    Qiao, Yao
    Shin, Jung-Im
    Sang, Yingying
    Inker, Lesley A.
    Secora, Alex
    Luo, Shengyuan
    Coresh, Josef
    Alexander, G. Caleb
    Jackson, John W.
    Chang, Alex R.
    Grams, Morgan E.
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (11) : 2220 - 2229
  • [6] Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease
    Qiao, Yao
    Shin, Jung-Im
    Sang, Yingying
    Inker, Lesley
    Secora, Alex
    Coresh, Josef
    Alexander, G. Caleb
    Jackson, John
    Chang, Alex
    Grams, Morgan
    [J]. CIRCULATION, 2019, 139
  • [7] Use of renin angiotensin system inhibitors in patients with chronic kidney disease
    Adam, W. R.
    Wright, J. R.
    [J]. INTERNAL MEDICINE JOURNAL, 2016, 46 (05) : 626 - 630
  • [8] Hepatitis C virus infection in chronic kidney disease: paradigm shift in management
    Kim, So Mi
    Song, Il Han
    [J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2018, 33 (04): : 670 - 678
  • [9] Paradigm shift in understanding Acute kidney injury in patients with chronic liver disease: From pathophysiology to defining disease entities
    Scurt, Florian Gunnar
    Bose, Katrin
    Canbay, Ali
    Mertens, Peter R.
    Chatzikyrkou, Christos
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (03): : 254 - 266
  • [10] Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease
    Ferrari, Paolo
    [J]. NEPHROLOGY, 2007, 12 (01) : 81 - 89
12345